---
title: "FDA approves Mimrylo (rusfertide) — weekly injection for polycythemia vera"
id: "stat-news-0-stat-fda-approves-protagonist-and-takeda-s-drug-for-rare-blood-cancer"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-fda-approves-protagonist-and-takeda-s-drug-for-rare-blood-cancer"
content_type: "clinical_feed_article"
specialty: "Hematology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/?utm_campaign=rss"
published_at: "2026-08-30T18:30:18.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# FDA approves Mimrylo (rusfertide) — weekly injection for polycythemia vera
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-fda-approves-protagonist-and-takeda-s-drug-for-rare-blood-cancer
- **Specialty:** [Hematology](https://medichelpline.com/clinical-feed/hematology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/?utm_campaign=rss)
- **Published At:** 2026-08-30T18:30:18.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The FDA approved **rusfertide**, branded as **Mimrylo**, for the treatment of **polycythemia vera**. - The drug was developed by Protagonist Therapeutics and will be marketed by Takeda under the Mimrylo name. - Mimrylo is given as a **weekly injection**. - Polycythemia vera is described as a chronic, slow-growing blood cancer characterized by overproduction of red blood cells that increases risk of heart attack, stroke, and blood clots. - STAT reports the approval and cites an FDA press announcement; the article indicates additional details of the story are behind a STAT+ paywall. - The published story states the FDA described the product as a new kind of treatment for this rare disorder. - The source article does not report specific clinical trial results, safety and adverse event data, comparative efficacy, recommended dosing beyond weekly administration, pricing, or an expected commercial launch timeline. - Regulatory and company statements referenced include an FDA approval announcement and identification of Protagonist as developer and Takeda as the commercial partner; the STAT piece is authored by Adam Feuerstein and dated Aug. 30, 2026. - Further details and fuller reporting were available only to STAT+ subscribers per the source article.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [Mental Health](https://www.statnews.com/topic/mental-health/) [cardiology](https://www.statnews.com/topic/cardiology/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Biotech](https://www.statnews.com/category/biotech/) # FDA approves Protagonist and Takeda’s drug for rare blood cancer ## Mimrylo, a weekly injection, is a new kind of treatment for polycythemia vera * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_729644280_Editorial_Use_Only-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Aug. 30, 2026 Senior Writer, Biotech ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") adam.feuerstein@statnews.com Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. The Food and Drug Administration on Friday [approved](https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-its-kind-polycythemia-vera-rare-blood-disorder) a new treatment for a rare and slow-growing cancer that causes an overproduction of red blood cells. The drug, called rusfertide, was developed by the biotech company Protagonist Therapeutics. It will be sold by Takeda, the Japanese pharma company, under the brand name Mimrylo. Advertisement Administered via a weekly injection, Mimrylo was cleared to treat polycythemia vera, a chronic blood cancer in which overproduction of red blood cells thickens a patient’s blood, resulting in higher risk for life-threatening heart attacks, strokes, and blood clots. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [Cancer](https://www.statnews.com/topic/cancer/), [STAT+](https://www.statnews.com/topic/stat-plus/), [Takeda](https://www.statnews.com/topic/takeda/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") 2. Senior Writer, Biotech 1. [](https://x.com/adamfeuerstein "X") 2. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2024/03/Biotech-Scorecard-Logo-NoSTAT-640x290.png) ### STAT+ Newsletter Senior writer Adam Feuerstein's unfiltered, uncompromising analysis on the biotech world Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/marc-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Stanford president releases emails to rebut fraud and cover-up allegations in new book](https://www.statnews.com/2026/08/27/marc-tessier-lavigne-responds-theo-baker-book-misconduct-stanford-genentech/) 2. ![](https://www.statnews.com/wp-content/uploads/2018/10/STAT_Alnylam03-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua](https://www.statnews.com/2026/08/30/alnylam-attr-astrazeneca-wainua-attruby-heart-disease/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_508908319_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Novartis drug cut inflammation. Can it improve heart outcomes? ](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_180917809-80x80.jpeg) [Nurse practitioner trainees find themselves stymied by shortage of clinical mentors](https://www.statnews.com/2026/08/24/nurse-practitioner-preceptor-shortage-clinical-placement-challenges/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-1222271719-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Nurses seek a seat at the table as they fight expanding clinical AI](https://www.statnews.com/2026/08/11/nurses-seek-involvement-clinical-ai-decisions/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/image-15-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Inside Moderna and Merck’s cancer vaccine triumph](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/Revmed_campus2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves new pancreatic cancer drug expected to usher in new era of treatment](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/F0372048-Lipoprotein_A_particle_illustration-1-e1787689211295-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [New treatments for common cardiovascular risk factor near the market, with billions at stake](https://www.statnews.com/2026/08/26/lp-a-drugs-novartis-amgen-lilly-potential-heart-disease-blockbuster/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2270934863-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Comments on OMB research rule mysteriously removed from federal website](https://www.statnews.com/2026/08/25/russell-vought-omb-funding-comments-daughter-benefited-nih-research/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_151544736-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicaid transgender care rule sets precedent that could restrict coverage of other drugs](https://www.statnews.com/2026/08/24/transgender-care-ban-precedent-could-be-broadly-applied-medicaid-states/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 30, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua ](https://www.statnews.com/2026/08/30/alnylam-attr-astrazeneca-wainua-attruby-heart-disease/) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching ](https://www.statnews.com/2026/08/28/biotech-news-astrazeneca-ionis-detail-surprise-failure-of-heart-disease-drug/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Cytokinetics details trial win for what could be its next approval ](https://www.statnews.com/2026/08/28/cytokinetics-myqorzo-aficamten-nhcm-acacia-trial-success/) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 27, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves Roivant therapy for rare autoimmune disease ](https://www.statnews.com/2026/08/27/fda-approves-roivant-therapy-for-rare-autoimmune-disease/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) D.C. Diagnosis D.C. Diagnosis August 27, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Hospitals plot their response to funding cuts ](https://www.statnews.com/2026/08/27/hospitals-lobby-medicaid-cuts-rasonque-approved-dc-diagnosis/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Inside Moderna and Merck’s cancer vaccine triumph ](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) By [Matthew Herper](https://www.statnews.com/staff/matthew-herper/), [Jason Mast](https://www.statnews.com/staff/jason-mast/), and [Angus Chen](https://www.statnews.com/staff/angus-chen/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves new pancreatic cancer drug expected to usher in new era of treatment ](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Angus Chen](https://www.statnews.com/staff/angus-chen/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: When it comes to women’s health, money talks ](https://www.statnews.com/2026/08/26/womens-
## Related Clinical Research

- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Shingrix shingles vaccine associated with modestly lower cardiovascular risk in natural-experiment](https://medichelpline.com/clinical-feed/stat-news-0-newer-shingles-vaccine-linked-to-lower-heart-disease-risk-natural-experiment.md)
- [Impact of a 4-Week Vegan Diet on Inflammation and Biological Aging](https://medichelpline.com/clinical-feed/medical-news-today-0-just-4-weeks-on-a-vegan-diet-linked-to-changes-in-inflammation-aging.md)
- [Stopping Statins at Age 75 in Low‑Risk Adults: French Trial Found No Increase in Deaths](https://medichelpline.com/clinical-feed/stat-news-0-stopping-statins-in-people-over-75-at-low-risk-for-heart-disease-didn-t.md)
- [Increasing stroke risk in younger adults requires targeted prevention and updated risk assessment](https://medichelpline.com/clinical-feed/plos-medicine-0-stroke-risk-in-younger-age-groups-is-increasing-and-requires-targeted-prevention.md)

## Navigation
- [← Back to Hematology Feed](https://medichelpline.com/clinical-feed/hematology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.